Amid COVID-19 pandemic, Gilead cuts production time for experimental drug in half
April 06, 2020 at 10:26 AM EDT
The Foster City company hopes to produce 1 million course treatments for COVID-19 patients by the end of the year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|